Effects of the proapoptotic drug prodigiosin on cell cycle-related proteins in Jurkat T cells

dc.contributor.authorPérez Tomás, Ricardo E.
dc.contributor.authorMontaner Ramoneda, Beatriz
dc.date.accessioned2016-12-01T11:30:44Z
dc.date.available2016-12-01T11:30:44Z
dc.date.issued2003-04
dc.date.updated2016-12-01T11:30:49Z
dc.description.abstractProdigiosin (PG) is a red pigment produced by Serratia marcescens with immunosuppressive and apoptotic activities. In this study, we sought to examine the effect of PG on cell cycle-related proteins. The antiproliferative activity of PG was tested using human Jurkat leukaemia T cells in culture. PG-inhibited cell proliferation was determined using thymidine incorporation assay. PG-arrested cell cycle was analysed using immunoblot analysis with specific antibodies against cell cycle-related proteins and kinase assays of cdk2. Apoptosis was determined by Hoechst staining and analysis of DNA fragmentation. PG inhibited cyclin E, cdk2, p27 and p21, the induction of the cyclin A-cdk2 and cyclin E-cdk2 kinase activity, and the phosphorylation of Rb in leukaemic Jurkat cells. We confirmed that PG induces apoptosis by the characteristic DNA laddering pattern and condensed nuclei or apoptotic bodies identified by fluorescence microscopy. These results indicate that PG and other family members form a new group of molecules with a common mechanism of action and specific molecular targets, raising the possibility of their therapeutic use as antineoplastic drugs.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec514780
dc.identifier.issn0213-3911
dc.identifier.urihttps://hdl.handle.net/2445/104340
dc.language.isoeng
dc.publisherUniversidad de Murcia
dc.relation.isformatofReproducció del document publicat a: https://digitum.um.es/xmlui/bitstream/10201/21441/1/Effects%20of%20the%20proapoptotic%20drug%20prodigiosin.pdf
dc.relation.ispartofHistology and Histopathology, 2003, vol. 18, num. 2, p. 379-385
dc.rightscc-by-nc-nd (c) Universidad de Murcia, 2003
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationSerratia marcescens
dc.subject.classificationApoptosi
dc.subject.classificationProliferació cel·lular
dc.subject.classificationQuimioteràpia
dc.subject.classificationImmunosupressió
dc.subject.classificationCèl·lules T
dc.subject.classificationCicle cel·lular
dc.subject.classificationDrogues
dc.subject.classificationProteïnes
dc.subject.classificationDivisió cel·lular
dc.subject.otherSerratia marcescens
dc.subject.otherApoptosis
dc.subject.otherCell proliferation
dc.subject.otherChemotherapy
dc.subject.otherImmunosuppression
dc.subject.otherT cells
dc.subject.otherCell cycle
dc.subject.otherDrugs of abuse
dc.subject.otherProteins
dc.subject.otherCell division
dc.titleEffects of the proapoptotic drug prodigiosin on cell cycle-related proteins in Jurkat T cells
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
514780.pdf
Mida:
612.62 KB
Format:
Adobe Portable Document Format